GlassScriptPhysician profile
Ayham Mouawad
NPI 1417261611
$4,103.10
in general payments reported to CMS, 2019-2025
22 companies · $1,226 in 2025
The $1,226 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $40.73 · 2021: $396 · 2022: $883 · 2023: $351 · 2024: $472 · 2025: $1,226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,048.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $585.73 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $353.93 | 2021-2024 | Xarelto |
| Abiomed | $276.30 | 2024-2025 | Impella |
| Penumbra, INC. | $242.18 | 2025 | Indigo System |
| Paratek Pharmaceuticals, INC. | $241.95 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.20 | 2019-2024 | Jardiance |
| Glaxosmithkline, LLC. | $234.93 | 2023 | Arexvy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $219.38 | 2025 | Lifevest |
| Stryker Corporation | $164.49 | 2025 | Flowtriever |
| Averitas Pharma INC. | $158.12 | 2024 | Qutenza |
| Pfizer INC. | $134.11 | 2019-2021 | |
| Melinta Therapeutics, LLC | $125.00 | 2019 | |
| Smith+Nephew, INC. | $125.00 | 2019 | |
| Medtronic, INC. | $124.98 | 2025 | Hawkone |
| Gilead Sciences, INC. | $124.73 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $123.50 | 2022 | |
| Stemline Therapeutics INC. | $122.87 | 2025 | Orserdu |
| Ferring Pharmaceuticals INC. | $115.74 | 2023 | Rebyota |
| Tetraphase Pharmaceuticals, INC. | $109.14 | 2019 | |
| Urovant Sciences INC | $102.19 | 2022 | |
| Silk Road Medical, INC. | $92.48 | 2019 | |
| Integra Lifesciences Corporation | $91.15 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayham Mouawad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.